在家族性高胆固醇血症中长非编码RNA:生物标记物,治疗方法和精密医学中的AI
Hussam Daghistani1,2, Gehan A Hegazy1, Manal Alkhalofah1
1Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Lipids in health and disease
|May 21, 2025
概括
长非编码RNAs (lncRNAs) 是脂质新陈代谢的关键调节者,并显示为家族高胆固醇血症 (FH) 的生物标志物. 研究正在探索IncRNAs用于新型诊断和基于RNA的疗法,以管理心血管疾病风险.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在脂质代谢中的调节作用.
- 家庭性高胆固醇血症 (FH) 是一种遗传性疾病,导致高LDL-C和早发性心血管疾病 (CVD).
- 目前的FH诊断有局限性,需要新的生物标志物.
研究的目的:
- 审查 lncRNAs 在 FH 病变发生过程中的机制性参与.
- 探索 lncRNAs作为潜在的非侵入性生物标志物和FH的治疗点.
- 讨论人工智能和转录学方面的进展,以在FH中发现lncRNA.
主要方法:
- 文献综述侧重于lncRNA功能在脂质代谢和FH中的作用.
- 在胆固醇调节和动脉样硬化中分析特定的lncRNAs (LeXis,CHROME,H19).
- 检查基于RNA的新兴治疗策略和人工智能驱动的发现方法.
主要成果:
- lncRNAs在胆固醇生物合成,运输和排泄中发挥关键作用,影响FH.
- 特定的lncRNAs涉及动脉样硬化进展,为精准医学提供了潜力.
- 人工智能和单细胞转录组学正在推进对FH的IncRNA鉴定.
结论:
- lncRNAs代表了具有前途的非侵入性生物标志物和FH的治疗点.
- 基于RNA的治疗药物有可能恢复FH患者的脂质平衡.
- 需要进行进一步的研究,以克服基于 lncRNA 的 FH 管理临床翻译方面的挑战.
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
496
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
496
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
siRNA - Small Interfering RNAs
16.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.4K
Cholesterol: Significance and Regulation
487
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
487
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K


